lactobacillus sporogenes
Cell therapyexperimental
Heyndrickxia coagulans is a lactic acid–forming bacterial species. This species was transferred to Weizmannia in 2020, then to Heyndrickxia in 2023. — Wikipedia
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
1
Earliest trial started Apr 1, 2005 (NCT00947336)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaHeyndrickxia coagulans ↗
- WikipediaBacillus coagulans ↗
Also known as
- lactobacillus sporogenes
- lactobacillus sporogens
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02130713 | Phase 4 | Jan 1, 2012 | University of Roma La Sapienza |
| NCT00947336 | Phase 3 | Apr 1, 2005 | Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, Jhaver Research Foundation Limited |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Govind Ballabh Pant Institute of Postgraduate Medical Education and Research | Academic/Hospital | 1 | 1 | 1 | 2005 |
| Jhaver Research Foundation Limited | Academic/Hospital | 1 | 0 | 1 | 2005 |
| University of Roma La Sapienza | Academic/Hospital | 1 | 1 | 1 | 2012 |
3 organizations
Page 1 / 1